Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Urology
Volume 2013 (2013), Article ID 241073, 6 pages
http://dx.doi.org/10.1155/2013/241073
Case Report

Adjuvant Radiotherapy for Synchronous Bilateral Testicular Seminoma: A Case Report and a Review of the Pertinent Literature

1Department of Radiation Oncology, University of Minnesota Medical Center, Minneapolis, MN 55455, USA
2Department of Urology, University of Minnesota Medical Center, Minneapolis, MN 55455, USA
3Department of Medicine, Division of Hematology, Oncology, Bone Marrow Transplantation, Masonic Cancer Center, University of Minnesota Medical Center, Minneapolis, MN 55455, USA

Received 8 March 2013; Accepted 23 April 2013

Academic Editors: S.-S. Chen, G. L. Gravina, and F. Ramezanzadeh

Copyright © 2013 Daniel A. Jones et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. American Cancer Society, Cancer Facts & Figures 2012, American Cancer Society, Atlanta, Ga, USA, 2012.
  2. S. R. Patel, R. L. Richardson, and L. Kvols, “Synchronous and metachronous bilateral testicular tumors. Mayo clinic experience,” Cancer, vol. 65, no. 1, pp. 1–4, 1990. View at Publisher · View at Google Scholar
  3. E. H. Wanderås, S. D. Fosså, and S. Tretli, “Risk of a second germ cell cancer after treatment of a primary germ cell cancer in 2201 Norwegian male patients,” European Journal of Cancer Part A, vol. 33, no. 2, pp. 244–252, 1997. View at Publisher · View at Google Scholar · View at Scopus
  4. C. L. Coogan, R. S. Foster, G. R. Simmons, P. G. Tognoni, B. J. Roth, and J. P. Donohue, “Bilateral testicular tumors: management and outcome in 21 patients,” Cancer, vol. 83, no. 3, pp. 547–552, 1998. View at Publisher · View at Google Scholar
  5. D. J. A. Sonneveld, H. Schraffordt Koops, D. T. Sleijfer, and H. J. Hoekstra, “Bilateral testicular germ cell tumours in patients with initial stage I disease: prevalence and prognosis—a single centre's 30 years' experience,” European Journal of Cancer, vol. 34, no. 9, pp. 1363–1367, 1998. View at Publisher · View at Google Scholar · View at Scopus
  6. D. Ondrus, M. Hornnak, and J. Mat'oska, “Bilateral testicular germ-cell tumors—a single centre long-term experience,” International Urology and Nephrology, vol. 33, no. 3, pp. 521–524, 2001. View at Publisher · View at Google Scholar
  7. M. Che, P. Tamboli, J. Y. Ro et al., “Bilateral testicular germ cell tumors: twenty-year experience at M. D. Anderson Cancer Center,” Cancer, vol. 95, no. 6, pp. 1228–1233, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Ohyama, A. Kyan, M. Satoh et al., “Bilateral testicular tumors: a report of nine cases with long-term follow-up,” International Journal of Urology, vol. 9, no. 3, pp. 173–177, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Géczi, F. Gomez, M. Bak, and I. Bodrogi, “The incidence, prognosis, clinical and histological characteristics, treatment, and outcome of patients with bilateral germ cell testicular cancer in Hungary,” Journal of Cancer Research and Clinical Oncology, vol. 129, no. 5, pp. 309–315, 2003. View at Google Scholar · View at Scopus
  10. J. M. Holzbeierlein, P. C. Sogani, and J. Sheinfeld, “Histology and clinical outcomes in patients with bilateral testicular germ cell tumors: the Memorial Sloan Kettering Cancer Center experience 1950 to 2001,” Journal of Urology, vol. 169, no. 6, pp. 2122–2125, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Theodore, M. J. Terrier-Lacombe, A. Laplanche et al., “Bilateral germ-cell tumours: 22-Year experience at the Institut Gustave Roussy,” British Journal of Cancer, vol. 90, no. 1, pp. 55–59, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Hentrich, N. Weber, T. Bergsdorf, B. Liedl, R. Hartenstein, and A. Gerl, “Management and outcome of bilateral testicular germ cell tumors: twenty-five year experience in Munich,” Acta Oncologica, vol. 44, no. 6, pp. 529–536, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. K. P. Dieckmann and U. Pichlmeier, “Clinical epidemiology of testicular germ cell tumors,” World Journal of Urology, vol. 22, no. 1, pp. 2–14, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. K. P. Dieckmann, V. Loy, and P. Bttner, “Prevalence of bilateral testicular germ cell tumours and early detection based on contralateral testicular intra-epithelial neoplasia,” British Journal of Urology, vol. 71, no. 3, pp. 340–345, 1993. View at Google Scholar · View at Scopus
  15. S. D. Fosså, J. Chen, S. J. Schonfeld et al., “Risk of contralateral testicular cancer: a population-based study of 29515 U.S. Men,” Journal of the National Cancer Institute, vol. 97, no. 14, pp. 1056–1066, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. D. R. Feldman, “The approach to the patient with synchronous bilateral germ cell tumors: a lesson in oncologic prioritization,” Oncology, vol. 24, no. 8, pp. 761–763, 2010. View at Google Scholar · View at Scopus
  17. S. Giacchetti, Y. Raoul, P. Wibault, J. P. Droz, B. Court, and F. Eschwege, “Treatment of stage I testis seminoma by radiotherapy: long-term results—a 30-year experience,” International Journal of Radiation Oncology Biology Physics, vol. 27, no. 1, pp. 3–9, 1993. View at Google Scholar · View at Scopus
  18. P. Kellokumpu-Lehtinen and A. Halme, “Results of treatment in irradiated testicular seminoma patients,” Radiotherapy and Oncology, vol. 18, no. 1, pp. 1–7, 1990. View at Publisher · View at Google Scholar · View at Scopus
  19. W. G. Jones, S. D. Fossa, G. M. Mead et al., “Randomized trial of 30 versus 20 Gy in the adjuvant treatment of stage I testicular seminoma: a report on Medical Research Council Trial TE18, European Organisation for the Research and Treatment of Cancer Trial 30942 (ISRCTN18525328),” Journal of Clinical Oncology, vol. 23, no. 6, pp. 1200–1208, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. S. D. Fosså, A. Horwich, J. M. Russell et al., “Optimal planning target volume for stage I testicular seminoma: a medical research council randomized trial,” Journal of Clinical Oncology, vol. 17, no. 4, pp. 1146–1154, 1999. View at Google Scholar · View at Scopus
  21. R. T. D. Oliver, G. M. Mead, G. J. S. Rustin et al., “Randomized trial of carboplatin versus radiotherapy for stage I seminoma: mature results on relapse and contralateral testis cancer rates in MRC TE19/EORTC 30982 study (ISRCTN27163214),” Journal of Clinical Oncology, vol. 29, no. 8, pp. 957–962, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. National Comprehensive Cancer Network, “NCCN Clinical Practice Guidelines in Oncology. Testicular Cancer. Version 1,” 2012, http://www.nccn.org/professionals/physician_gls/pdf/testicular.pdf. View at Google Scholar
  23. M. Soper, J. Hastings, H. Cosmatos, J. Slezak, R. Wang, and K. Lodin, “Observation versus adjuvant radiation or chemotherapy in the management of stage I seminoma: clinical outcomes and prognostic factors for relapse in a large US cohort,” American Journal of Clinical Oncology, 2012. View at Google Scholar
  24. J. Aparicio, P. Maroto, X. del Muro et al., “Risk-adapted treatment in clinical stage I testicular seminoma: the third spanish germ cell cancer group study,” Journal of Clinical Oncology, vol. 29, no. 35, pp. 4677–4681, 2011. View at Publisher · View at Google Scholar
  25. A. Heidenreich, L. Weißbach, W. Höltl, P. Albers, S. Kliesch, and K. U. Köhrmann, “Organ sparing surgery for malignant germ cell tumor of the testis,” Journal of Urology, vol. 166, no. 6, pp. 2161–2165, 2001. View at Google Scholar · View at Scopus
  26. H. Steiner, L. Höltl, C. Maneschg et al., “Frozen section analysis-guided organ-sparing approach in testicular tumors: technique, feasibility, and long-term results,” Urology, vol. 62, no. 3, pp. 508–513, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. L. Weissbach, “Organ preserving surgery of malignant germ cell tumors,” Journal of Urology, vol. 153, no. 1, pp. 90–93, 1995. View at Publisher · View at Google Scholar · View at Scopus
  28. O. Yossepowitch and J. Baniel, “Role of organ-sparing surgery in germ cell tumors of the testis,” Urology, vol. 63, no. 3, pp. 421–427, 2004. View at Google Scholar · View at Scopus
  29. E. Tomita, T. Kondo, H. Nakazawa, F. Ito, Y. Hashimoto, and K. Tanabe, “Successful testis preservation for bilateral testicular tumors with a new chemotherapy-based protocol: initial results of three cases,” International Journal of Urology, vol. 14, no. 9, pp. 879–882, 2007. View at Publisher · View at Google Scholar · View at Scopus